lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway

Overview of attention for article published in OncoTargets and therapy, May 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 76 followers.

lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway. https://t.co/6AdwgKAqYH https://t.co/9yFiOX8CJR

Reply Repost Favourite